HCI-026 breast cancer PDX Product
HCI-026 PDX: Sample collected in 2016 from spine metastasis of female, age 55 at time of collection with a primary diagnosis of IDC; 2013.
HCI-026 PDX: Sample collected in 2016 from spine metastasis of female, age 55 at time of collection with a primary diagnosis of IDC; 2013.
HCI-006 PDX: Sample collected from same donor as HCI-005 from pleural effusion of Caucasian female, with a primary diagnosis of mixed multicentric disease
HCI-009 PDX: Sample collected from ascites of Caucasian female, age 66 with a primary diagnosis of poorly differentiated adenocarcinoma (1985).
HCI-010 PDX: Human breast cancer-derived xenograft retains high fidelity to original tumour. Valuable resources for drug discovery and precision oncology.
HCI-011 PDX: Human breast cancer-derived xenograft retains high fidelity to original tumour. Valuable resources for drug discovery and precision oncology.
HCI-012 PDX: Human breast cancer-derived xenograft retains high fidelity to original tumour. Valuable resources for drug discovery and precision oncology.
HCI-013-EI PDX: Human breast cancer-derived xenograft retains high fidelity to original tumour. Valuable resource for drug discovery and precision oncology.
HCI-018 PDX: Human breast cancer-derived xenograft retains high fidelity to original tumour. Valuable resources for drug discovery and precision oncology.
HCI-001 PDX: Sample from breast tumour collected from Caucasian female, with a primary diagnosis of IDC; 2007 (stage IV) and no history of smoking
Breast cancer patient derived xenograft PDX
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.